Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMassachusetts General Hospital
About this trial
Researchers at Massachusetts General Hospital are looking to see if a program created to help improve thinking and memory can work for refugees with traumatic brain injury (TBI). They're checking if this program is practical and if people find it helpful.
The study will have two groups. Participants will complete a first questionnaire and then be assigned to a group by chance. One group will participate in the program immediately and then answer the second questionnaire (approximately 3 months after the first questionnaire they did). Then they will wait and then answer the third and final questionnaire approximately 6 months after the first one.
The second group will wait and answer the second questionnaire approximately 3 months after the first one. Then they will receive the program and answer the third and final questionnaire (approximately 6 months after the first one they did.)
Eligibility criteria
Qualifiers
Identify as an asylum seeker, refugee or have been granted asylum or other form of humanitarian relief.
Mild or moderate TBI sustained after the age of 18
Age 18-65
Subjective cognitive impairment
Disqualifiers
Participation in cognitive rehabilitation treatment current or in past 3 months
Severe TBI or TBI only sustained under the age of 18
Diagnosis of bipolar, psychosis, active substance use, self-reported current active suicidal ideation or plan (Potential participants can be screened again after 30 days in the case of suicidal ideation)
Trial design
Treatments tested in this trial
- A Trauma-informed, Paraprofessional Delivered Virtual Cognitive Rehabilitation Program
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Massachusetts General Hospital
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Source ClinicalTrials.gov